| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 150.53B | 143.76B | 150.66B | 151.31B | 153.52B | 132.22B |
| Gross Profit | 31.92B | 30.88B | 31.66B | 30.33B | 29.45B | 27.35B |
| EBITDA | 20.22B | 14.20B | 17.25B | 15.97B | 13.15B | 13.80B |
| Net Income | 12.25B | 12.88B | 9.01B | 6.74B | 5.52B | 5.60B |
Balance Sheet | ||||||
| Total Assets | 188.47B | 201.84B | 190.53B | 192.79B | 174.09B | 167.28B |
| Cash, Cash Equivalents and Short-Term Investments | 15.84B | 15.53B | 15.19B | 16.16B | 10.39B | 14.12B |
| Total Debt | 10.27B | 7.61B | 10.95B | 12.34B | 15.41B | 13.20B |
| Total Liabilities | 67.30B | 68.17B | 69.34B | 74.71B | 71.18B | 69.87B |
| Stockholders Equity | 119.86B | 132.19B | 119.81B | 116.85B | 101.33B | 96.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.51B | 5.46B | 8.27B | -2.02B | 5.76B |
| Operating Cash Flow | 0.00 | 14.59B | 11.05B | 12.86B | 2.52B | 9.25B |
| Investing Cash Flow | 0.00 | 1.37B | -2.99B | -387.00M | -2.97B | -3.34B |
| Financing Cash Flow | 0.00 | -15.81B | -9.04B | -6.95B | -3.58B | -14.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥617.79B | 17.43 | 13.63% | 1.95% | -1.79% | 1.03% | |
73 Outperform | ¥177.28B | 10.76 | ― | 2.66% | -4.58% | 51.25% | |
73 Outperform | ¥102.25B | 5.86 | ― | 3.74% | -3.93% | 3.02% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥360.50B | 4.33 | 8.35% | 2.73% | -3.16% | -32.06% | |
57 Neutral | ¥14.14B | 27.32 | ― | 2.41% | -3.10% | 33.69% | |
46 Neutral | ¥307.83B | -3.58 | -20.43% | 3.72% | -13.16% | -410.43% |